Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026)
Alcon (ALC) recorded quarterly Non-Current Deferred Tax Liability of $944.0 million in Q1 2026, little changed quarter-over-quarter from $941.0 million in Q4 2025, and up 545.28% on a YoY basis from $146.3 million in Q1 2025.
Alcon (ALC) Non-Current Deferred Tax Liability (2009 - 2026) Analysis & Trends
Alcon's Non-Current Deferred Tax Liability history runs 11 years deep, the most recent figure standing at $944.0 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability rose 545.28% year-over-year to $944.0 million; the TTM figure through Mar 2026 stood at $944.0 million (up 545.28% YoY), while the FY2025 annual figure was $941.0 million, up 29.97% from the prior year.
- Non-Current Deferred Tax Liability was $944.0 million for Q1 2026 at Alcon, roughly flat from $941.0 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.0 billion in Q4 2022 to a low of -$212.0 million in Q1 2025.
- Historically, Non-Current Deferred Tax Liability has averaged $903.5 million across 5 years, with a median of $911.0 million in 2025.
- The sharpest annual moves came in 2025 and 2026: Non-Current Deferred Tax Liability tumbled 125.92% in 2025, then soared 545.28% in 2026.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.0 billion in 2022, then tumbled by 59.99% to $797.0 million in 2023, then dropped by 9.16% to $724.0 million in 2024, then gained by 29.97% to $941.0 million in 2025, then grew by 0.32% to $944.0 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $944.0 million (Q1 2026), $941.0 million (Q4 2025), and $911.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn |
| 10 | Alcon | 25,681.50 | -1.66 Bn | 1.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 944.00 Mn |
| Mar 31, 2026 | 944.00 Mn |
| Dec 31, 2025 | 941.00 Mn |
| Dec 31, 2025 | 941.00 Mn |
| Sep 30, 2025 | 911.00 Mn |
| Sep 30, 2025 | 911.00 Mn |
| Jun 30, 2025 | 857.00 Mn |
| Jun 30, 2025 | 857.00 Mn |
| Mar 24, 2025 | -212.00 Mn |
| Mar 24, 2025 | -212.00 Mn |
| Dec 31, 2024 | 724.00 Mn |
| Dec 31, 2024 | 724.00 Mn |
| Sep 30, 2024 | 785.00 Mn |
| Sep 30, 2024 | 785.00 Mn |
| Jun 30, 2024 | 792.00 Mn |
| Jun 30, 2024 | 792.00 Mn |
| Mar 31, 2024 | 818.00 Mn |
| Mar 31, 2024 | 818.00 Mn |
| Dec 31, 2023 | 797.00 Mn |
| Dec 31, 2023 | 797.00 Mn |